Comparison of responses to rat and human adrenomedullin in the hindlimb vascular bed of the cat

被引:20
作者
Champion, HC [1 ]
Lambert, DG [1 ]
McWilliams, SM [1 ]
Shah, MK [1 ]
Murphy, WA [1 ]
Coy, DH [1 ]
Kadowitz, PJ [1 ]
机构
[1] TULANE UNIV, SCH MED, DEPT PHARMACOL & MED SL83, NEW ORLEANS, LA 70112 USA
关键词
adrenomedullin (ADM); vasodilator responses; regional vascular bed; cAMP-dependent mechanism;
D O I
10.1016/S0167-0115(97)01003-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Responses to rat (r) adrenomedullin (ADM) and human (h) ADM were compared in the hindlimb vascular bed of the cat under conditions of controlled blood flow. Intra-arterial injections of rADM and hADM in doses of 0.03-1 nmol caused dose-related decreases in hindlimb perfusion pressure. In terms of relative vasodilator activity, rADM was similar to hADM. The time course of the vasodilator response and the recovery half times (T-1/2) for the vasodilator response to rADM and hADM were not significantly different. Decreases in hindlimb perfusion pressure in response to rADM and hADM were not altered by the calcitonin gene-related peptide receptor antagonist, rCGRP(8-37), at the same time, vasodilator responses to calcitonin gene-related peptide (CGRP) were significantly reduced. The T-1/2 of the vasodilator response to rADM and hADM were significantly greater after administration of the cAMP-selective, type IV phosphodiesterase inhibitor, rolipram. These data demonstrate that decreases in hindlimb perfusion pressure in response to rADM and hADM are similar and that vasodilator responses to rADM are not dependent on the activation of CGRP receptors in I-he hindlimb vascular bed of the cat. These data further suggest that decreases in hindlimb perfusion pressure in response to rADM are mediated by smooth muscle increases in cAMP levels. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:161 / 165
页数:5
相关论文
共 24 条
  • [1] EFFECTS OF ADRENOMEDULLIN, CALCITONIN-GENE-RELATED PEPTIDE, AND AMYLIN ON CEREBRAL-CIRCULATION IN DOGS
    BASKAYA, MK
    SUZUKI, Y
    ANZAI, M
    SEKI, Y
    SAITO, K
    TAKAYASU, M
    SHIBUYA, M
    SUGITA, K
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1995, 15 (05) : 827 - 834
  • [2] Adrenomedullin-(22-52) antagonizes vasodilator responses to CGRP but not adrenomedullin in the cat
    Champion, HC
    Santiago, JA
    Murphy, WA
    Coy, DH
    Kadowitz, PJ
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1997, 272 (01) : R234 - R242
  • [3] SYNTHETIC HUMAN ADRENOMEDULLIN AND ADM15-52 HAVE POTENT SHORT-LASTING VASODILATOR ACTIVITY IN THE PULMONARY VASCULAR BED OF THE CAT
    CHENG, DY
    DEWITT, BJ
    WEGMANN, MJ
    COY, DH
    BITAR, K
    MURPHY, WA
    KADOWITZ, PJ
    [J]. LIFE SCIENCES, 1994, 55 (14) : PL251 - PL256
  • [4] STRUCTURE-ACTIVITY RELATIONSHIP OF ADRENOMEDULLIN, A NOVEL VASODILATORY PEPTIDE, IN CULTURED RAT VASCULAR SMOOTH-MUSCLE CELLS
    EGUCHI, S
    HIRATA, Y
    IWASAKI, H
    SATO, K
    WATANABE, TX
    INUI, T
    NAKAJIMA, K
    SAKAKIBARA, S
    MARUMO, F
    [J]. ENDOCRINOLOGY, 1994, 135 (06) : 2454 - 2458
  • [5] SPECIFIC RECEPTORS FOR ADRENOMEDULLIN IN CULTURED RAT VASCULAR SMOOTH-MUSCLE CELLS
    EGUCHI, S
    HIRATA, Y
    KANO, H
    SATO, K
    WATANABE, Y
    WATANABE, TX
    NAKAJIMA, K
    SAKAKIBARA, S
    MARUMO, F
    [J]. FEBS LETTERS, 1994, 340 (03) : 226 - 230
  • [6] EFFECTS OF CALCITONIN-GENE-RELATED PEPTIDE RECEPTOR ANTAGONISTS ON RENAL ACTIONS OF ADRENOMEDULLIN
    ELHAWARY, AM
    POON, J
    PANG, CCY
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (07) : 1133 - 1140
  • [7] Entzeroth Michael, 1995, Life Sciences, V56, pPL19
  • [8] FENG CJ, 1994, LIFE SCI, V55, pPL433
  • [9] REGIONAL HEMODYNAMIC-EFFECTS OF HUMAN AND RAT ADRENOMEDULLIN IN CONSCIOUS RATS
    GARDINER, SM
    KEMP, PA
    MARCH, JE
    BENNETT, T
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (03) : 584 - 591
  • [10] ADRENOMEDULLIN AND CALCITONIN-GENE-RELATED PEPTIDE IN THE RAT ISOLATED KIDNEY AND IN THE ANESTHETIZED RAT - IN-VITRO AND IN-VIVO EFFECTS
    HAYNES, JM
    COOPER, ME
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 280 (01) : 91 - 94